Last reviewed · How we verify
Morphine with clonidine
At a glance
| Generic name | Morphine with clonidine |
|---|---|
| Sponsor | Northwestern University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- Intrathecal MoRphine Versus Transabdominal Plane Block (TAP) Block for AnalGesic Management in Elective Caesarean Section (PHASE4)
- Prospective Opioid-Free AIS Fusion (PHASE4)
- General Versus Regional Anesthesia in Peripheral Arterial Surgery (NA)
- Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain (PHASE3)
- Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair (PHASE4)
- Minimal Opioid Use After Total Hip Replacement (THR) (PHASE4)
- Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Morphine with clonidine CI brief — competitive landscape report
- Morphine with clonidine updates RSS · CI watch RSS
- Northwestern University portfolio CI